Litmus Health, a company helping pharma companies use wearable devices to improve the efficiency of Phase I and II drug trials, is coming out of public beta and announcing a trial with the University of Chicago testing the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients. The trial is funded via a grant from Takeda Pharmaeuticals.
"I see so many patients filling...
When Larry Smarr started exploring the biochemistry of his body, he turned to his microbiome to find answers. At TEDMED 2013, Smarr talked about the steps he took in the months before he discovered he had Crohn’s disease.
At first, Smarr used apps like Zeo and Fitbit to monitor his sleeping and exercise respectively. Eventually, Smarr delved deeper, turning his attention to blood work and stool...
The UCLA Center for Inflammatory Bowl Diseases just completed the pilot phase of a program that equips patients who have Crohn's disease and ulcerative colitis with iPads to help them track and monitor their conditions while staying in touch with their care team throughout the day as needed. Now that the pilot phase is over, UCLA is enrolling about 250 patients in the program.
"Using a tablet...
